Coronary Stent Market Growth Trend & Forecast with latest research study released by Delvens evaluating the market risk side analysis, highlighting opportunities, and leveraging strategic and tactical decision-making support. The report provides information on market trends and development, growth drivers, technologies, and the changing investment structure of the Global market, the global Coronary Stent Market size is projected to reach a CAGR of 8.9% during the forecast to 2030.

Get Free Sample Report: https://www.delvens.com/get-free-sample/coronary-stent-market

Coronary stents are small elastic tubes used for the treatment of narrowed and blocked coronary arteries in patients with coronary artery disease (CAD). These reduce the symptoms of chest pain (angina) and aid in the treatment of a heart attack. These types of stents are also called as heart stents or cardiac stents. They comprise metal mesh and are implanted in constricted coronary arteries during a technique known as percutaneous coronary intervention (PCI) or angioplasty.

Regional Analysis

North America holds the largest market share for coronary stents due to the dominance of the top companies present in the global market. There is also an increase in the aging population, an increase in the prevalence of heart diseases, and technological advancements found in the region. In addition, other factors, such as good reimbursement scenario, have been driving the North American coronary stent market.

Key Players of Coronary Stent Market:

·        Abbott Laboratories

·        B. Braun Medical Inc.

·        Biosensors International Group, Ltd.

·        BIOTRONIK SE & Co. KG

·        Boston Scientific Corporation and More

Recent Developments: Coronary Stent Market

Abbott announced that it has received approval for Xience Sierra. The product is the newest generation of the company’s gold standard Xience everolimus-eluting coronary stent system. Abbott’s latest approval will not just benefit the company but will have a direct impact on the growth of the overall market in the coming years.

Abbott received U.S. FDA approval for Xience Sierra in May 2018, which is a XIENCE everolimus-eluting coronary stent system.

Coronary Stent Market is segmented into Product type, biomaterial, end user and region.

On the basis of Product Type

·        Drug eluting stent

·        Bare metal coronary stent

·        Bioabsorbable stent

On the basis of Biomaterial 

·        Metallic biomaterial

·        Polymeric biomaterial

·        Natural biomaterial

On the basis of End-User 

·        Hospitals

·        Ambulatory surgical centres 

On the basis of Region

·        Asia Pacific

·        North America

·        Europe

·        South America

·        Middle East & Africa

Access Full Report: https://www.delvens.com/report/coronary-stent-market

In addition to the market data for Coronary Stent Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.

More Reports from Delvens:

Bioprocess Validation Market

Coronary Stent Market

Automotive Diagnostic Scan Tools Market

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

Contact us:

Unit No. 01, 3rd Floor, Plot No. 56, Block B

Sector 2 Noida, Near Noida Sector 15 Metro Station 201301, IN

+44 20 3290 6466

+0120- 4903958

sales@delvens.com